ADVI’s Lindsay Bealor Greenleaf discusses the Trump administration’s health care policy approach with Modern Healthcare
This approach separates the Trump administration from prior ones, according to Lindsay Bealor Greenleaf, a director of healthcare consulting firm ADVI. Instead of merely condemning the drug industries for prices, it is angling to use the drug supply chain to reduce costs.
[el-text]
Written by Virgil Dickson
***excerpt***
This approach separates the Trump administration from prior ones, according to Lindsay Bealor Greenleaf, a director of healthcare consulting firm ADVI. Instead of merely condemning the drug industries for prices, it is angling to use the drug supply chain to reduce costs.
***end excerpt***
***
[/el-text]
View full article here
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.